Spinosin mitigates bone loss in ovariectomy rats by activating the Nrf2/HO-1 pathway, which reduces oxidative stress and improves mitochondrial function
Molecular and Cellular Endocrinology · 2026-11 · 621 · 112866
DOI: 10.1016/j.mce.2026.112866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-11. Verfasst von Yitian Bu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Key La…. Hauptthemen laut MEDLINE: Oxidative Stress, NF-E2-Related Factor 2, Ovariectomy, Mitochondria. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Postmenopausal osteoporosis (PMOP) is driven by oxidative stress and impaired osteogenic potential. We investigated the protective effects of Spinosin (SPI) using rat bone marrow mesenchymal stem cells (BMSCs) and an ovariectomized (OVX) rat model. Oxidative stress was induced by H2O2. We measured reactive oxygen species (ROS) levels, mitochondrial ultrastructure via transmission electron microscopy (TEM), and the nuclear factor erythroid 2-related factor 2 (Nrf2) / heme oxygenase-1 (HO-1) signaling pathway. Results showed that SPI significantly reduced ROS accumulation and preserved mitochondrial integrity and membrane potential. Mechanistically, SPI activated the Nrf2/HO-1 pathway, upregulating osteogenic markers such as RUNX2. In vivo, oral SPI treatment (20 or 40mg/kg) effectively restored bone volume and microarchitecture in OVX rats. These bone-protective effects were largely abolished by the Nrf2 inhibitor ML385. In conclusion, SPI alleviates oxidative stress-induced BMSC dysfunction and bone loss through Nrf2/HO-1 activation, highlighting its potential as a natural therapeutic agent for PMOP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou, 325000, China.
- People's Hospital of Lucheng, Wenzhou, 325000, China.
- Wenzhou Medical University, Wenzhou, 325000, China.
- Department of Gynecological Oncology, Wenzhou Central Hospital, Wenzhou, Zhejiang, 325000, China.
- Department of Orthopedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou, 325000, China.…
Förderung
- Zhejiang Province Natural Science Foundation
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Bu, Y., Huang, Y., Yang, J., Fei, Y., Cheng, D., Chen, W., & Yang, L. (2026). Spinosin mitigates bone loss in ovariectomy rats by activating the Nrf2/HO-1 pathway, which reduces oxidative stress and improves mitochondrial function. Molecular and Cellular Endocrinology, 621, 112866. https://doi.org/10.1016/j.mce.2026.112866
Vancouver
Bu Y, Huang Y, Yang J, Fei Y, Cheng D, Chen W, et al. Spinosin mitigates bone loss in ovariectomy rats by activating the Nrf2/HO-1 pathway, which reduces oxidative stress and improves mitochondrial function. Molecular and Cellular Endocrinology. 2026;621:112866. doi:10.1016/j.mce.2026.112866
BibTeX
@article{Bu2026,
author = {Bu, Yitian and Huang, Yixun and Yang, Jiayi and Fei, Yijun and Cheng, Dandan and Chen, Weikai and Yang, Lei},
title = {Spinosin mitigates bone loss in ovariectomy rats by activating the Nrf2/HO-1 pathway, which reduces oxidative stress and improves mitochondrial function},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
volume = {621},
pages = {112866},
doi = {10.1016/j.mce.2026.112866}
}
EUVIMED